↑ Rising
Business
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports
McKesson and CD&R are moving to acquire at-home infusion therapy provider Option Care Health in a deal valued at $5.8 billion.
Option Care Health
1 trends tracked about this subject — the full history, oldest to newest below.